2025 WCLC Clinical New Advances In Non-Small Cell Lung Cancer
Автор: eChinaHealth
Загружено: 2025-09-17
Просмотров: 121
Описание:
Agenda
Opening Remark
Dr. Jonathan Cheng, SystImmune, Inc.
Keynote Presentation
Dr. Wenfeng Fang, Sun Yat-Sen University Cancer Center
Phase I/II Study of Iza-Bren (BL-B01D1) as Monotherapy in Patients With Locally Advanced or Metastatic EGFR Mutated NSCLC
Dr. Fei Zhou, Shanghai East Hospital
Phase II Study of Iza-Bren (BL-B01D1) Combo With Osimertinib in EGFR Mutated Locally Advanced or Metastatic NSCLC Patients
Panel Discussion
Moderator:
Dr. Jonathan Cheng, SystImmune, Inc.
Panelists:
Dr. Wenfeng Fang, Sun Yat-Sen University Cancer Center
Dr. Fei Zhou, Shanghai East Hospital
Dr. Xiuning Le, MD Anderson Cancer Center, USA
Dr. Stephen Liu, Georgetown University Lombardi Comprehensive Cancer Center, USA
Dr. David Perez Callejo, Bristol Myers Squibb
Closing Remark
Dr. Jonathan Cheng, SystImmune, Inc.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
